![Matti Heinonen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 41 199 $ al 31/05/2026
Mr. Matti Heinonen is a Chief Executive Officer at Gentian Diagnostics ASA. Mr. Heinonen was previously employed as a Chief Commercial Officer by Medix Biochemica Oy Ab.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENTIAN DIAGNOSTICS ASA 0,07 % | 12/03/2026 | 10.569 ( 0,07 % ) | 41 199 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENTIAN DIAGNOSTICS | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
Medix Biochemica Oy Ab
 Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Develops, produces, and markets monoclonal antibodies, antibody services, & recombinant antigens for in vitro diagnostics industry | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Medix Biochemica Oy Ab
Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Develops, produces, and markets monoclonal antibodies, antibody services, & recombinant antigens for in vitro diagnostics industry | Health Technology |
Gentian Diagnostics ASA
 Gentian Diagnostics ASA Medical SpecialtiesHealth Technology Develops and manufactures in-vitro diagnostic products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
